Drreddys Laboratories | Ativos



Assets Alterar Data
ANI Pharmaceuticals USD 1.29B 8.73M 2025-03
Aurora Cannabis CAD 866.52M 57.75M 2024-12
Bayer EUR 109.18B 1.67B 2025-03
Canopy Growth CAD 1.16B 68.13M 2024-12
Cipla INR 373.87B 27.32B 2025-03
Corcept Therapeutics USD 846.46M 5.9M 2025-03
Drreddys Laboratories INR 481.06B 15.1B 2024-12
GlaxoSmithKline GBP 60.71B 1.24B 2025-03
Hikma Pharmaceutical USD 4.85B 167M 2024-06
Lonza CHF 19.73B 1.85B 2024-12
Novartis USD 102.25B 1.28B 2024-12
Pacira USD 1.59B 33.15M 2025-03
Prestige Brands USD 3.4B 72.72M 2025-03
Richter Gedeon HUF 1.6T 116.26B 2024-12
Sun Pharmaceuticals INR 921.01B 39.85B 2025-03
Supernus Pharmaceuticals USD 1.37B 25.37M 2024-12
Teva Pharmaceutical Industries USD 38.42B 911M 2025-03



Drreddys Laboratories Ativos - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - May 2025.